FDA Inspection 1162749 — Frederick L. Locke, M.D.
The FDA completed an inspection of Frederick L. Locke, M.D. on February 3, 2022 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 3, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Tampa, FL (United States)
Additional Details
Clinical Investigator (CI)